These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7541603)

  • 1. High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells.
    Schleiffenbaum B; Rüegg R; Zimmermann D; Fehr J
    Am J Hematol; 1995 Jul; 49(3):221-31. PubMed ID: 7541603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
    Kingreen D; Dalal BI; Heyman M; Phillips GL; Horsman D; Kidd P; Loughran TP
    Am J Hematol; 1995 Dec; 50(4):234-6. PubMed ID: 7485096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphatic leukemias of T and NK cell type.
    Kingreen D; Siegert W
    Leukemia; 1997 Apr; 11 Suppl 2():S46-9. PubMed ID: 9178839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
    Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
    Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
    Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
    Kato N; Yasukawa K; Onozuka T; Kikuta H
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteropathy-type T-cell lymphoma expressing NK-cell intraepithelial lymphocyte (NK-IEL) phenotype.
    Inagaki N; Asaoka D; Mori KL; Sohda N; Miura I; Miwa H; Sato N; Oshimi K
    Leuk Lymphoma; 2004 Jul; 45(7):1471-4. PubMed ID: 15359651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large granular lymphocyte proliferation with the natural killer-cell phenotype.
    Chan WC; Gu LB; Masih A; Nicholson J; Vogler WR; Yu G; Nasr S
    Am J Clin Pathol; 1992 Mar; 97(3):353-8. PubMed ID: 1543158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NK-cell lymphomas and NK-like T-cell lymphomas].
    Oshimi K
    Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer T-cell lymphoma of the tongue.
    Cho KJ; Cho SG; Lee DH
    Ann Otol Rhinol Laryngol; 2005 Jan; 114(1 Pt 1):55-7. PubMed ID: 15697163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia.
    Gentile TC; Uner AH; Hutchison RE; Wright J; Ben-Ezra J; Russell EC; Loughran TP
    Blood; 1994 Oct; 84(7):2315-21. PubMed ID: 7522625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
    Drexler HG; Matsuo Y
    Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder.
    Huang Q; Chang KL; Gaal KK; Weiss LM
    Am J Surg Pathol; 2005 Nov; 29(11):1540-3. PubMed ID: 16224224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
    Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
    Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversed C.P.C.: Aggressive NK-cell leukemia/lymphoma].
    Koyama T
    Rinsho Byori; 2001 Mar; Suppl 115():140-3. PubMed ID: 11391932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.
    Cheung MM; Chan JK; Wong KF
    Semin Hematol; 2003 Jul; 40(3):221-32. PubMed ID: 12876671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer-cell lymphoma involving the gynecologic tract.
    Mhawech P; Medeiros LJ; Bueso-Ramos C; Coffey DM; Gei AF; Shahab I
    Arch Pathol Lab Med; 2000 Oct; 124(10):1510-3. PubMed ID: 11035585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.